COVID-19 infection is linked to a subsequent heightened risk of poor cardiovascular health and death, particularly among those whose infection is severe requiring hospital admission, finds a large UK Biobank...

By NewsDesk  @infectiousdiseasenews The NIH has reported that many individuals with COVID-19 develop abnormal blood clots from high inflammation, which can lead to serious health complications and...

By NewsDesk  @infectiousdiseasenews Following the initial reports of rare side effects after vaccination with the AstraZeneca vaccine (Vaxevria), a registry study was initiated quickly. The study includes...

By NewsDesk  @infectiousdiseasenews The U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Johnson...

By NewsDesk  @infectiousdiseasenews In a follow-up on Norway’s pause in the use of the AstraZeneca vaccine, the Norwegian Institute of Public Health recommended stopping further use of the AstraZeneca...

As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen ) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare...

By NewsDesk  @bactiman63 A few weeks ago, the European Medicines Agency (EMA) reported that the COVID-19 Vaccine AstraZeneca was not associated with an increase in the overall risk of blood clots. Today,...

By NewsDesk  @infectiousdiseasenews The Canadian National Advisory Committee on Immunization (NACI) Monday recommended that the AstraZeneca COVID-19 vaccine should not be used in adults under 55 years...

The European Medicines Agency (EMA) reported Thursday that the benefits of getting the COVID-19 Vaccine AstraZeneca still outweigh the risks despite possible link to rare blood clots with low blood platelets. They...

By NewsDesk  @bactiman63 The European Medicines Agency (EMA) and the Medical Products Agency are investigating reports of suspected side effects of blood clots in combination with bleeding in individuals...